Telefonaktiebolaget Lm Ericsson (Publ)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Peng Lv

Hai Feng Wang

Xiquan Zhang

Ling Yang

Xin Tian

Shanchun Wang

Xunqiang Wang

Xiangjian Wang

Hai Jiang

Zhong Wang

Haiming Bai

Hai Wang

The present invention provides a quinoline derivative for treating triple-negative breast cancer and use thereof in preparing a pharmaceutical composition for treating a tumor. Specifically, the present invention relates to use of quinoline derivative 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropylamine in the treatment of triple-negative breast cancer, 

Quinoline derivative for treatment of triple-negative breast cancer

A method for communications is proposed. The method may comprise obtaining, by a terminal device, network addresses of another terminal device from a message broker to which the terminal device and the another terminal device are registered. At least one of the terminal device and the another terminal device is connected to a cellular network. The method may further comprise initiating a connectivity check procedure to determine one or more candidate paths through which the terminal device has connectivity to the another terminal device. The one or more candidate paths are from at least two paths associated with the network addresses of the another terminal device. The method may further comprise selecting a path for the terminal device and the another terminal device among the one or more candidate paths, based at least in part on a predefined criterion.

Connection establishement in a cellular network

Growing community of inventors

Jiangsu, China

Peng Lv